Total valid tests n | 4570 |
General resistance profile | |
Isoniazid susceptible, rifampicin susceptible | 1213 (26.5) |
Isoniazid resistant, rifampicin susceptible | 521 (11.4) |
Isoniazid susceptible, rifampicin resistant | 198 (4.3) |
Isoniazid resistant, rifampicin resistant (MDR) | 2638 (57.7) |
Isoniazid resistance in MDR | |
katG 315T mutation without known inhA mutations | 883 (33.5) |
inhA 8C, 8A, 15T or 16G mutation without known katG mutations | 20 (0.7) |
katG 315T mutation and inhA 8C, 8A, 15T or 16G mutation | 1440 (54.6) |
MDR without known katG or inhA mutations# | 295 (11.2) |
Rifampicin resistance in MDR | |
rpoB 531L mutation | 1995 (75.6) |
rpoB 526Y mutation | 24 (0.9) |
rpoB 526D mutation | 5 (0.2) |
rpoB 516V mutation | 66 (2.5) |
Multiple rpoB mutations | 49 (1.9) |
MDR without known rpoB mutations# | 499 (18.9) |